# FDA Inspection 1004086 - Hillestad Pharmaceuticals USA, Inc. - March 03, 2017

Source: https://www.keypedia.com/records/fda_inspections/hillestad-pharmaceuticals-usa-inc/b4c5f92e-ca2b-427f-8cb2-f04442e26ffa
Source feed: FDA_Inspections

> FDA Inspection 1004086 for Hillestad Pharmaceuticals USA, Inc. on March 03, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1004086
- Company Name: Hillestad Pharmaceuticals USA, Inc.
- Inspection Date: 2017-03-03
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1274587 - 2025-06-27](https://www.keypedia.com/records/fda_inspections/hillestad-pharmaceuticals-usa-inc/0abcfa68-62bf-4f3a-8517-280bce6b45fe)
- [FDA Inspection 1274587 - 2025-06-27](https://www.keypedia.com/records/fda_inspections/hillestad-pharmaceuticals-usa-inc/7bfc458e-40ff-43b1-838b-0a00ca2b788d)
- [FDA Inspection 1179316 - 2022-08-23](https://www.keypedia.com/records/fda_inspections/hillestad-pharmaceuticals-usa-inc/226aff18-586a-4cfd-858a-e7ccd3a21f06)
- [FDA Inspection 1135747 - 2021-01-06](https://www.keypedia.com/records/fda_inspections/hillestad-pharmaceuticals-usa-inc/92c426e8-32a7-4bf9-9466-c7e78e1cb558)
- [FDA Inspection 1093954 - 2019-06-20](https://www.keypedia.com/records/fda_inspections/hillestad-pharmaceuticals-usa-inc/f3cace60-4b36-4ae4-bcfc-5714c4a3bcf0)

Company: https://www.keypedia.com/companies/hillestad-pharmaceuticals-usa-inc/36591d69-da95-4bb1-8f7f-bfcd52b06cae

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c